Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17,20-lyase in immature hypophysectomized rats treated with gonadotrophin

D. C. Johnson, L. H. Crane

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

A study was designed to compare the effects of exogenous and endogenous oestrogens upon the expression of steroid 17α-hydroxylase/C17,20-lyase (CYP17) in the immature hypophysectomized rat ovary. C17,20-lyase activity was measured ex vivo using [21-14C]progesterone, while serum concentrations of androstenedione indicated in vivo activity. Immunocytochemistry was used to localize the enzyme within the ovary. Activity of CYP17 increased dramatically and remained high in thecal and interstitial cells after injection of equine chorionic gonadotrophin, even though serum oestradiol (OE2) levels exceeded 2 nmol/l. Production of comparable serum levels by the use of Silastic capsules containing OE2 greatly suppressed but did not stop, expression of the enzyme induced by repeated doses of human chorionic gonadotrophin (hCG). Subcutaneous implantation of Silastic capsules (1 cm) containing diethylstilboestrol (DES) stimulated follicular growth and increased ovarian weight by 67%, 5 days later. injection of 50 IU hCG at various times after removal of the implant produced time-dependent changes in CYP17 activity and serum androstenedione levels, when measured 30 h later. Although the initial effect of removal of DES was an increase in CYP17 activity, delaying injection of hCG resulted in a reduced response. The results indicated that: (1) endogenous oestrogens do not inhibit CYP17 expression; (2) exogenous oestrogens only reduce the number of thecal/interstitial cells expressing CYP17 when they are exposed to hCG; (3) pretreatment with oestrogen removes the ovarian interstitial but not the thecal cell expression of CYP17 in response to hCG; and (4) oestrogens can be stimulatory for CYP17 expression in thecal cells.

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalJournal of Endocrinology
Volume145
Issue number1
DOIs
Publication statusPublished - 1 Jan 1995
Externally publishedYes

Fingerprint

Steroid 17-alpha-Hydroxylase
Lyases
Mixed Function Oxygenases
Gonadotropins
Estrogens
Chorionic Gonadotropin
Diethylstilbestrol
Androstenedione
Serum
Injections
Capsules
Ovary
Equine Gonadotropins
Enzymes
Progesterone
Estradiol
Immunohistochemistry
Weights and Measures

Cite this

@article{da9d10a77d864d6e8b896515aa610f5c,
title = "Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17,20-lyase in immature hypophysectomized rats treated with gonadotrophin",
abstract = "A study was designed to compare the effects of exogenous and endogenous oestrogens upon the expression of steroid 17α-hydroxylase/C17,20-lyase (CYP17) in the immature hypophysectomized rat ovary. C17,20-lyase activity was measured ex vivo using [21-14C]progesterone, while serum concentrations of androstenedione indicated in vivo activity. Immunocytochemistry was used to localize the enzyme within the ovary. Activity of CYP17 increased dramatically and remained high in thecal and interstitial cells after injection of equine chorionic gonadotrophin, even though serum oestradiol (OE2) levels exceeded 2 nmol/l. Production of comparable serum levels by the use of Silastic capsules containing OE2 greatly suppressed but did not stop, expression of the enzyme induced by repeated doses of human chorionic gonadotrophin (hCG). Subcutaneous implantation of Silastic capsules (1 cm) containing diethylstilboestrol (DES) stimulated follicular growth and increased ovarian weight by 67{\%}, 5 days later. injection of 50 IU hCG at various times after removal of the implant produced time-dependent changes in CYP17 activity and serum androstenedione levels, when measured 30 h later. Although the initial effect of removal of DES was an increase in CYP17 activity, delaying injection of hCG resulted in a reduced response. The results indicated that: (1) endogenous oestrogens do not inhibit CYP17 expression; (2) exogenous oestrogens only reduce the number of thecal/interstitial cells expressing CYP17 when they are exposed to hCG; (3) pretreatment with oestrogen removes the ovarian interstitial but not the thecal cell expression of CYP17 in response to hCG; and (4) oestrogens can be stimulatory for CYP17 expression in thecal cells.",
author = "Johnson, {D. C.} and Crane, {L. H.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1677/joe.0.1450059",
language = "English",
volume = "145",
pages = "59--67",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17,20-lyase in immature hypophysectomized rats treated with gonadotrophin. / Johnson, D. C.; Crane, L. H.

In: Journal of Endocrinology, Vol. 145, No. 1, 01.01.1995, p. 59-67.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17,20-lyase in immature hypophysectomized rats treated with gonadotrophin

AU - Johnson, D. C.

AU - Crane, L. H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - A study was designed to compare the effects of exogenous and endogenous oestrogens upon the expression of steroid 17α-hydroxylase/C17,20-lyase (CYP17) in the immature hypophysectomized rat ovary. C17,20-lyase activity was measured ex vivo using [21-14C]progesterone, while serum concentrations of androstenedione indicated in vivo activity. Immunocytochemistry was used to localize the enzyme within the ovary. Activity of CYP17 increased dramatically and remained high in thecal and interstitial cells after injection of equine chorionic gonadotrophin, even though serum oestradiol (OE2) levels exceeded 2 nmol/l. Production of comparable serum levels by the use of Silastic capsules containing OE2 greatly suppressed but did not stop, expression of the enzyme induced by repeated doses of human chorionic gonadotrophin (hCG). Subcutaneous implantation of Silastic capsules (1 cm) containing diethylstilboestrol (DES) stimulated follicular growth and increased ovarian weight by 67%, 5 days later. injection of 50 IU hCG at various times after removal of the implant produced time-dependent changes in CYP17 activity and serum androstenedione levels, when measured 30 h later. Although the initial effect of removal of DES was an increase in CYP17 activity, delaying injection of hCG resulted in a reduced response. The results indicated that: (1) endogenous oestrogens do not inhibit CYP17 expression; (2) exogenous oestrogens only reduce the number of thecal/interstitial cells expressing CYP17 when they are exposed to hCG; (3) pretreatment with oestrogen removes the ovarian interstitial but not the thecal cell expression of CYP17 in response to hCG; and (4) oestrogens can be stimulatory for CYP17 expression in thecal cells.

AB - A study was designed to compare the effects of exogenous and endogenous oestrogens upon the expression of steroid 17α-hydroxylase/C17,20-lyase (CYP17) in the immature hypophysectomized rat ovary. C17,20-lyase activity was measured ex vivo using [21-14C]progesterone, while serum concentrations of androstenedione indicated in vivo activity. Immunocytochemistry was used to localize the enzyme within the ovary. Activity of CYP17 increased dramatically and remained high in thecal and interstitial cells after injection of equine chorionic gonadotrophin, even though serum oestradiol (OE2) levels exceeded 2 nmol/l. Production of comparable serum levels by the use of Silastic capsules containing OE2 greatly suppressed but did not stop, expression of the enzyme induced by repeated doses of human chorionic gonadotrophin (hCG). Subcutaneous implantation of Silastic capsules (1 cm) containing diethylstilboestrol (DES) stimulated follicular growth and increased ovarian weight by 67%, 5 days later. injection of 50 IU hCG at various times after removal of the implant produced time-dependent changes in CYP17 activity and serum androstenedione levels, when measured 30 h later. Although the initial effect of removal of DES was an increase in CYP17 activity, delaying injection of hCG resulted in a reduced response. The results indicated that: (1) endogenous oestrogens do not inhibit CYP17 expression; (2) exogenous oestrogens only reduce the number of thecal/interstitial cells expressing CYP17 when they are exposed to hCG; (3) pretreatment with oestrogen removes the ovarian interstitial but not the thecal cell expression of CYP17 in response to hCG; and (4) oestrogens can be stimulatory for CYP17 expression in thecal cells.

UR - http://www.scopus.com/inward/record.url?scp=0028907154&partnerID=8YFLogxK

U2 - 10.1677/joe.0.1450059

DO - 10.1677/joe.0.1450059

M3 - Article

VL - 145

SP - 59

EP - 67

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -